Biodexa Pharmaceuticals Plc (NASDAQ:BDRX - Get Free Report) was down 3.5% during trading on Monday . The stock traded as low as $1.24 and last traded at $1.38. Approximately 178,356 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 595,523 shares. The stock had previously closed at $1.43.
Biodexa Pharmaceuticals Trading Down 0.6 %
The stock has a fifty day simple moving average of $2.16 and a two-hundred day simple moving average of $3.92.
About Biodexa Pharmaceuticals
(
Get Free Report)
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Featured Articles
Before you consider Biodexa Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Biodexa Pharmaceuticals wasn't on the list.
While Biodexa Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
